Mondalis, Ambali L.
HRN: 22-00-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
RIFAXIMIN 200MG (TAB)
12/31/2022
01/06/2023
PO
200mgtab
Bid
Intraabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes